News
Novo Nordisk CEO Lars Jørgensen to step down amid increasing pressure from obesity drug competition and recent share price ...
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...
Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a cultural and medical shift. I ...
Ro and LifeMD said they would offer access to all doses of the drug - which is a stronger version of Ozempic - for $499 ... but all people have to do via telehealth platforms is make an online ...
Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers , Ro and LifeMD to sell Wegovy, as it looks to ...
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
U.S. District Judge Mark Pittman in Texas denied compounders' bid for a preliminary injunction, according to the court docket. Pittman filed his legal reasoning under seal, but by denying the ...
Weight loss company WeightWatchers has filed for Chapter 11 bankruptcy protection after falling $1.15 billion into debt. The ...
The diet company known as WeightWatchers filed for bankruptcy saying its 62-year-old business model was now under threat amid ...
Deals with Hims & Hers, LifeMD and Ro follow dismissal of a lawsuit that challenged the FDA's determination Wegovy is no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results